Sevion Therapeutics (SVON) presented results from the Company’s Phase 1b/2a clinical trial of SNS01-T for the treatment of multiple myeloma and lymphoma last month
The Hygiology Post ® has been presenting information about a company formerly called Senesco Technologies which recently merged and rebranded to Sevion Therapeutics…